UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055978
Receipt number R000063972
Scientific Title An observational study on the association between oral microflora and ventilator-associated pneumonia in Vietnam
Date of disclosure of the study information 2024/10/29
Last modified on 2025/05/01 14:43:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An observational study on the association between oral microflora and ventilator-associated pneumonia in Vietnam

Acronym

Oral microbiome study

Scientific Title

An observational study on the association between oral microflora and ventilator-associated pneumonia in Vietnam

Scientific Title:Acronym

Oral microbiome study

Region

Japan Asia(except Japan)


Condition

Condition

ventilator-associated pneumonia

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Determine differences in oral microbiota in intubated patients with and without ventilator-associated pneumonia.

Basic objectives2

Others

Basic objectives -Others

Determining the relationship between bacterial flora in sputum and oral cavity specimens in patients with mechanically ventilated pneumonia.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Differences in oral flora in intubated patients with and without VAP using real-time PCR: during the first 7 days from case enrollment

Key secondary outcomes

Aassociation of bacterial flora in sputum and oral specimens in patients with VAP


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) 18 years of age or older

2) Patients who are intubated within 48 hours of admission and who will be admitted to the ICU within 48 hours of admission

3) Patients who have obtained consent to participate in the study from the patient or a surrogate

Key exclusion criteria

1) Patients with pneumonia prior to intubation

2) Patients who have been extubated/left ICU/deceased within 48 hours of intubation

3) Patients with trauma to the head, neck, or face

4) Patients whose oral cavity is contaminated with blood

5) Patients with trauma or signs of infection in the oral cavity prior to intubation

6) Those who are judged as unsuitable by the principal investigator or the project leader

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Sho
Middle name
Last name Saito

Organization

Japan Institute for Health Security

Division name

Disease Control and Prevention Center

Zip code

162-8655

Address

1-21-1 Toyama Shinjuku-ku, Tokyo, Japan

TEL

0332027181

Email

saito.s@jihs.go.jp


Public contact

Name of contact person

1st name Sho
Middle name
Last name Saito

Organization

Japan Institute for Health Security

Division name

Disease Control and Prevention Center

Zip code

162-8655

Address

1-21-1 Toyama Shinjuku-ku, Tokyo, Japan

TEL

0332027181

Homepage URL


Email

oralmicroflora@jihs.go.jp


Sponsor or person

Institute

Japan Institute for Health Security

Institute

Department

Personal name



Funding Source

Organization

SUNSTAR INC.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Certified Review Board of Japan Institute for Health Security

Address

1-21-1 Toyama Shinjuku-ku, Tokyo 162-8655, Japan

Tel

03-3202-7181

Email

kenkyu-shinsa@jihs.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Cho Ray Hospital (Ho Chi Minh City, Vietnam)


Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 09 Month 20 Day

Date of IRB

2024 Year 10 Month 11 Day

Anticipated trial start date

2024 Year 11 Month 25 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The prospective observational study will be conducted to evaluate the association between changes in oral flora and the occurrence of VAP in intubated patients.

The subjects will be patients admitted to the CRH who are (1) intubated within 48 hours of admission and (2) admitted to the ICU within 48 hours of admission.

During the observation period, oral wipes will be collected every day from day0-day7. Day8-day10 will be observed for the occurrence of VAP.

We will compare the total number of bacteria and alpha-diversity of oral specimens between the group that had VAP (VAP group) and the group that did not have VAP (non-VAP group) during the observation period to identify factors related to VAP in the oral microflora.


Management information

Registered date

2024 Year 10 Month 29 Day

Last modified on

2025 Year 05 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063972